Skip to main content
Clinical Trials/EUCTR2004-000948-25-ES
EUCTR2004-000948-25-ES
Active, not recruiting
Phase 1

Determinación de niveles plasmáticos e intracelulares de los inhibidores de la transcriptasa inversa análogos a nucleósidos (NRTI) y del análogo a nucleótido tenofovir disoproxil fumarato (TDF) en pacientes tratados con abacavir y/o lamivudina administrados con o sin TDF

Fundació de Lluita Contra la Sida0 sites27 target enrollmentSeptember 27, 2004

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Fundació de Lluita Contra la Sida
Enrollment
27
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2004
End Date
September 7, 2005
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Fundació de Lluita Contra la Sida

Eligibility Criteria

Inclusion Criteria

  • HIV\-infected patients \>18 years old
  • Indetectable viral load
  • HAART receiving treatment during previous three months including lamivudine and/or ABC and TDF, with ritonavir/lopinavir or nevirapine
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Interruption of the theraphy during the study
  • Concomitant treatment with other medicinal products that should interaction with antirretroviral treatment
  • Concomitant treatment with other antirretroviral drugs during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials